LXRX logo

Lexicon Pharmaceuticals (LXRX) Operating Profit

Annual Operating Profit

-$171.75 M
-$70.99 M-70.45%

December 31, 2023


Summary


Performance

LXRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLXRXprofitabilitymetrics:

Quarterly Operating Profit

-$63.69 M
-$8.34 M-15.06%

September 30, 2024


Summary


Performance

LXRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLXRXprofitabilitymetrics:

TTM Operating Profit

-$211.12 M
-$14.06 M-7.14%

September 30, 2024


Summary


Performance

LXRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLXRXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

LXRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.5%-40.5%-13.5%
3 y3 years+3.9%-175.8%-120.3%
5 y5 years-66.3%-125.1%-224.1%

LXRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.2%at low-175.8%at low-142.4%at low
5 y5-year-201.0%+3.9%-781.6%at low-224.1%+3.5%
alltimeall time-201.0%+3.9%-125.1%at low-203.0%+3.5%

Lexicon Pharmaceuticals Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$63.69 M(+15.1%)
-$211.12 M(+7.1%)
Jun 2024
-
-$55.35 M(+22.1%)
-$197.06 M(+6.0%)
Mar 2024
-
-$45.33 M(-3.0%)
-$185.94 M(+8.3%)
Dec 2023
-$171.75 M(+70.5%)
-$46.74 M(-5.8%)
-$171.75 M(+10.6%)
Sep 2023
-
-$49.63 M(+12.2%)
-$155.29 M(+20.6%)
Jun 2023
-
-$44.24 M(+42.1%)
-$128.75 M(+18.6%)
Mar 2023
-
-$31.14 M(+2.9%)
-$108.52 M(+7.7%)
Dec 2022
-$100.76 M(+15.7%)
-$30.28 M(+31.1%)
-$100.76 M(+5.2%)
Sep 2022
-
-$23.09 M(-3.8%)
-$95.81 M(+0.1%)
Jun 2022
-
-$24.01 M(+2.7%)
-$95.68 M(+6.7%)
Mar 2022
-
-$23.38 M(-7.7%)
-$89.63 M(+2.9%)
Dec 2021
-$87.09 M(-51.3%)
-$25.33 M(+10.3%)
-$87.09 M(+26.2%)
Sep 2021
-
-$22.96 M(+27.9%)
-$68.98 M(-25.2%)
Jun 2021
-
-$17.96 M(-13.8%)
-$92.17 M(-32.8%)
Mar 2021
-
-$20.84 M(+188.4%)
-$137.19 M(-23.3%)
Dec 2020
-$178.78 M(-205.1%)
-$7.22 M(-84.3%)
-$178.78 M(-18.3%)
Sep 2020
-
-$46.14 M(-26.7%)
-$218.78 M(-371.2%)
Jun 2020
-
-$62.98 M(+0.9%)
$80.68 M(-35.5%)
Mar 2020
-
-$62.44 M(+32.2%)
$125.11 M(-26.4%)
Dec 2019
$170.08 M(-264.7%)
-$47.22 M(-118.6%)
$170.08 M(-17.0%)
Sep 2019
-
$253.31 M(-1465.9%)
$204.93 M(-387.4%)
Jun 2019
-
-$18.55 M(+6.2%)
-$71.31 M(-14.1%)
Mar 2019
-
-$17.47 M(+41.2%)
-$83.04 M(-19.6%)
Dec 2018
-$103.28 M(-19.6%)
-$12.37 M(-46.1%)
-$103.28 M(-10.7%)
Sep 2018
-
-$22.93 M(-24.3%)
-$115.64 M(-5.4%)
Jun 2018
-
-$30.27 M(-19.7%)
-$122.23 M(-2.9%)
Mar 2018
-
-$37.71 M(+52.5%)
-$125.85 M(-2.1%)
Dec 2017
-$128.52 M(+0.5%)
-$24.73 M(-16.2%)
-$128.52 M(+2.7%)
Sep 2017
-
-$29.52 M(-12.9%)
-$125.14 M(-5.7%)
Jun 2017
-
-$33.89 M(-16.1%)
-$132.70 M(-2.0%)
Mar 2017
-
-$40.38 M(+89.2%)
-$135.35 M(+5.8%)
Dec 2016
-$127.87 M(-1263.3%)
-$21.35 M(-42.4%)
-$127.87 M(+692.4%)
Sep 2016
-
-$37.08 M(+1.5%)
-$16.14 M(+131.1%)
Jun 2016
-
-$36.54 M(+11.1%)
-$6.98 M(-344.2%)
Mar 2016
-
-$32.91 M(-136.4%)
$2.86 M(-74.0%)
Dec 2015
$10.99 M(-112.8%)
$90.39 M(-423.7%)
$10.99 M(-113.4%)
Sep 2015
-
-$27.92 M(+4.6%)
-$81.94 M(-0.5%)
Jun 2015
-
-$26.70 M(+7.8%)
-$82.32 M(+1.3%)
Mar 2015
-
-$24.77 M(+876.5%)
-$81.28 M(-5.3%)
Dec 2014
-$85.84 M(-17.9%)
-$2.54 M(-91.0%)
-$85.84 M(-18.7%)
Sep 2014
-
-$28.31 M(+10.3%)
-$105.56 M(-1.5%)
Jun 2014
-
-$25.66 M(-12.5%)
-$107.14 M(-2.3%)
Mar 2014
-
-$29.33 M(+31.7%)
-$109.62 M(+4.8%)
Dec 2013
-$104.58 M(+6.1%)
-$22.27 M(-25.5%)
-$104.58 M(-2.3%)
Sep 2013
-
-$29.88 M(+6.1%)
-$107.01 M(+6.6%)
Jun 2013
-
-$28.15 M(+15.9%)
-$100.35 M(+5.1%)
Mar 2013
-
-$24.29 M(-1.6%)
-$95.52 M(-3.1%)
Dec 2012
-$98.53 M
-$24.69 M(+6.4%)
-$98.53 M(-1.9%)
Sep 2012
-
-$23.22 M(-0.4%)
-$100.41 M(-2.4%)
Jun 2012
-
-$23.32 M(-14.6%)
-$102.89 M(-2.5%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$27.30 M(+2.7%)
-$105.50 M(-1.7%)
Dec 2011
-$107.33 M(+15.4%)
-$26.58 M(+3.4%)
-$107.33 M(+6.8%)
Sep 2011
-
-$25.69 M(-0.9%)
-$100.47 M(+1.5%)
Jun 2011
-
-$25.93 M(-11.0%)
-$99.03 M(+1.9%)
Mar 2011
-
-$29.14 M(+47.8%)
-$97.18 M(+4.5%)
Dec 2010
-$93.01 M(+3.4%)
-$19.71 M(-18.7%)
-$93.01 M(-2.2%)
Sep 2010
-
-$24.25 M(+0.7%)
-$95.14 M(+2.7%)
Jun 2010
-
-$24.07 M(-3.6%)
-$92.64 M(+1.4%)
Mar 2010
-
-$24.97 M(+14.3%)
-$91.35 M(+1.6%)
Dec 2009
-$89.96 M(-6.8%)
-$21.85 M(+0.4%)
-$89.96 M(+1.1%)
Sep 2009
-
-$21.76 M(-4.5%)
-$89.00 M(-3.3%)
Jun 2009
-
-$22.78 M(-3.3%)
-$92.06 M(-3.8%)
Mar 2009
-
-$23.57 M(+12.8%)
-$95.67 M(-0.9%)
Dec 2008
-$96.53 M(+28.8%)
-$20.89 M(-15.8%)
-$96.53 M(+2.6%)
Sep 2008
-
-$24.82 M(-5.9%)
-$94.11 M(+6.1%)
Jun 2008
-
-$26.39 M(+8.0%)
-$88.73 M(+10.5%)
Mar 2008
-
-$24.44 M(+32.3%)
-$80.30 M(+7.1%)
Dec 2007
-$74.95 M(+35.7%)
-$18.47 M(-5.0%)
-$74.95 M(+5.5%)
Sep 2007
-
-$19.44 M(+8.3%)
-$71.06 M(+10.5%)
Jun 2007
-
-$17.95 M(-6.0%)
-$64.32 M(+1.6%)
Mar 2007
-
-$19.09 M(+31.0%)
-$63.31 M(+14.6%)
Dec 2006
-$55.23 M(+52.9%)
-$14.57 M(+14.7%)
-$55.23 M(+58.1%)
Sep 2006
-
-$12.71 M(-25.0%)
-$34.94 M(-3.7%)
Jun 2006
-
-$16.93 M(+53.7%)
-$36.29 M(+7.1%)
Mar 2006
-
-$11.02 M(-292.6%)
-$33.87 M(-6.2%)
Dec 2005
-$36.12 M(-23.9%)
$5.72 M(-140.7%)
-$36.12 M(-16.6%)
Sep 2005
-
-$14.05 M(-3.2%)
-$43.30 M(+0.2%)
Jun 2005
-
-$14.52 M(+9.4%)
-$43.19 M(-4.3%)
Mar 2005
-
-$13.27 M(+809.9%)
-$45.12 M(-4.9%)
Dec 2004
-$47.45 M(-24.2%)
-$1.46 M(-89.5%)
-$47.45 M(-18.7%)
Sep 2004
-
-$13.95 M(-15.2%)
-$58.34 M(-1.6%)
Jun 2004
-
-$16.44 M(+5.4%)
-$59.26 M(-2.3%)
Mar 2004
-
-$15.60 M(+26.4%)
-$60.66 M(-3.1%)
Dec 2003
-$62.59 M(-0.5%)
-$12.34 M(-17.0%)
-$62.59 M(-3.5%)
Sep 2003
-
-$14.87 M(-16.7%)
-$64.84 M(-3.9%)
Jun 2003
-
-$17.85 M(+1.8%)
-$67.46 M(+3.4%)
Mar 2003
-
-$17.53 M(+20.2%)
-$65.25 M(+3.7%)
Dec 2002
-$62.89 M(+44.1%)
-$14.59 M(-16.6%)
-$62.89 M(+3.2%)
Sep 2002
-
-$17.49 M(+11.8%)
-$60.93 M(+18.6%)
Jun 2002
-
-$15.64 M(+3.1%)
-$51.40 M(+7.1%)
Mar 2002
-
-$15.18 M(+20.2%)
-$47.99 M(+10.0%)
Dec 2001
-$43.64 M(+23.0%)
-$12.63 M(+58.7%)
-$43.64 M(+4.3%)
Sep 2001
-
-$7.95 M(-35.0%)
-$41.85 M(+7.9%)
Jun 2001
-
-$12.24 M(+13.1%)
-$38.79 M(+18.0%)
Mar 2001
-
-$10.82 M(-0.2%)
-$32.86 M(-7.4%)
Dec 2000
-$35.48 M(+177.2%)
-$10.84 M(+121.7%)
-$35.48 M(+44.0%)
Sep 2000
-
-$4.89 M(-22.5%)
-$24.64 M(+24.8%)
Jun 2000
-
-$6.31 M(-53.0%)
-$19.75 M(+47.0%)
Mar 2000
-
-$13.44 M
-$13.44 M
Dec 1999
-$12.80 M
-
-

FAQ

  • What is Lexicon Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals annual operating profit year-on-year change?
  • What is Lexicon Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Lexicon Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals TTM operating profit year-on-year change?

What is Lexicon Pharmaceuticals annual operating income?

The current annual operating profit of LXRX is -$171.75 M

What is the all time high annual operating profit for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high annual operating income is $170.08 M

What is Lexicon Pharmaceuticals annual operating profit year-on-year change?

Over the past year, LXRX annual operating income has changed by -$70.99 M (-70.45%)

What is Lexicon Pharmaceuticals quarterly operating income?

The current quarterly operating profit of LXRX is -$63.69 M

What is the all time high quarterly operating profit for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high quarterly operating income is $253.31 M

What is Lexicon Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, LXRX quarterly operating income has changed by -$18.36 M (-40.50%)

What is Lexicon Pharmaceuticals TTM operating income?

The current TTM operating profit of LXRX is -$211.12 M

What is the all time high TTM operating profit for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high TTM operating income is $204.93 M

What is Lexicon Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, LXRX TTM operating income has changed by -$25.18 M (-13.54%)